Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYNexImmune Completes Dosing of First Cohort in Phase 1/2 Clinical Trial of NEXI-001 in Relapsed Acute Myelogenous Leukemia (AML)PREV STORYTampa General Hospital announces strategic partnership with Philips to innovate and improve patient experience